TMO Thermo Fisher Scientific
Updated
Healthcare · Measuring & Controlling Devices, Nec
Thermo Fisher Scientific (TMO) is a healthcare company in the Measuring & Controlling Devices, Nec industry, with a market capitalization of $228.7 billion. Shares last traded at $618.50, 3.9% below their 52-week high. Over the past year the stock is up 27.6%. TMO trades at a price-to-earnings ratio of 32.82, below the Measuring & Controlling Devices, Nec median of 39.61. Net profit margin is 15.0%, above the peer median of -1.6%. Revenue grew 3.9% year over year. The shares yield 0.3% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-27 · SEC EDGAR/XBRL.
TMO Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $636M | $1.68 | 9% |
| 2024-12-31 | $583M | $1.52 | 9% |
| 2023-12-31 | $523M | $1.35 | 9% |
| 2022-12-31 | $455M | $1.15 | 7% |
| 2021-12-31 | $395M | $0.99 | 5% |
| 2020-12-31 | $337M | $0.84 | — |
| 2019-12-31 | $297M | $0.74 | — |
| 2018-12-31 | $266M | $0.66 | — |
| 2017-12-31 | $237M | $0.60 | — |
| 2016-12-31 | $238M | $0.60 | — |
| 2013-12-31 | $216M | $0.59 | 17% |
| 2012-12-31 | $142M | $0.39 | 12% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $9.10 | 2026-07-31 |
| Q1 2026 | $4.43 | 2026-05-01 |
| FY 2025 | $17.74 | 2026-02-26 |
| Q3 2025 | $12.53 | 2025-10-31 |
| Q2 2026 | $8.26 | 2026-07-31 |
| Q1 2026 | $3.98 | 2026-05-01 |
Measuring & Controlling Devices, Nec peers
TMO vs 11 industry peers (Measuring & Controlling Devices, Nec), by market cap. Updated
| TMO | Thermo Fisher Scientific | $228.7B | 32.82 | 4.94 | 15.0% | +1.66% |
| ROK | Rockwell Automation | $47.6B | 39.61 | 5.30 | 13.4% | +0.71% |
| TRMB | Trimble Inc. | $14.0B | -133.83 | 3.70 | -2.8% | +1.71% |
| ONTO | Onto Innovation | $12.4B | -3083.48 | 12.32 | -0.4% | -0.86% |
| MIR | Mirion Technologies, Inc. | $4.1B | 167.54 | 4.00 | 2.4% | +7.74% |
| QSI | Quantum-Si Inc | $167M | -1.70 | 104.15 | — | +0.32% |
| OWLT | Owlet, Inc. | $147M | -16.46 | 1.28 | -7.8% | -1.08% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | $66M | -1.67 | 0.72 | -43.1% | -0.87% |
| BCHT | Birchtech Corp. | $31M | -10.26 | 1.62 | -15.8% | -0.84% |
| CAPA | Quantum-Si Inc | — | — | — | — | +8.52% |
| NIKI | Niki BioSolutions, Inc. | — | — | — | — | -3.17% |
🇨🇦 Thermo Fisher Scientific also trades on Cboe Canada as a CAD-hedged Canadian Depositary Receipt (CDR) under TMO. A CDR represents the same underlying TMO shares in Canadian dollars with the currency exposure hedged; this page tracks the US-listed shares.
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.